PTEN and Parkinson disease: In bladder cancer, breast invasive carcinoma, human coronary artery endothelial cell (HCAECs) injury, inflammatory responses, Parkinson's disease (PD), lung adenocarcinoma, and colon adenocarcinoma, miR-130 downregulates PTEN by directly targeting its mRNA [38], [39].